BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16679872)

  • 1. Effects of ERCC1 expression in peripheral blood on the risk of head and neck cancer.
    Yang M; Kim WH; Choi Y; Lee SH; Kim KR; Lee HS; Tae K
    Eur J Cancer Prev; 2006 Jun; 15(3):269-73. PubMed ID: 16679872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between XPC expression, genotype, and the risk of head and neck cancer.
    Yang M; Kang MJ; Choi Y; Kim CS; Lee SM; Park CW; Lee HS; Tae K
    Environ Mol Mutagen; 2005 May; 45(4):374-9. PubMed ID: 15657918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of nucleotide excision repair proteins in lymphocytes as a marker of susceptibility to squamous cell carcinomas of the head and neck.
    Wei Q; Wang LE; Sturgis EM; Mao L
    Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1961-6. PubMed ID: 16103444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck.
    Zhang Z; Shi Q; Sturgis EM; Spitz MR; Hong WK; Wei Q
    Clin Cancer Res; 2004 Dec; 10(23):7903-10. PubMed ID: 15585623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
    J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
    Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
    Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.
    An J; Liu Z; Hu Z; Li G; Wang LE; Sturgis EM; El-Naggar AK; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1633-8. PubMed ID: 17684138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck.
    Li G; Liu Z; Sturgis EM; Shi Q; Chamberlain RM; Spitz MR; Wei Q
    Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer.
    Zhou W; Liu G; Park S; Wang Z; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):491-6. PubMed ID: 15734977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use.
    Peters ES; McClean MD; Liu M; Eisen EA; Mueller N; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):476-82. PubMed ID: 15734975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck.
    Sturgis EM; Dahlstrom KR; Spitz MR; Wei Q
    Arch Otolaryngol Head Neck Surg; 2002 Sep; 128(9):1084-8. PubMed ID: 12220217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro benzo[a]pyrene diol epoxide-induced DNA adducts and risk of squamous cell carcinoma of head and neck.
    Li D; Wang LE; Chang P; El-Naggar AK; Sturgis EM; Wei Q
    Cancer Res; 2007 Jun; 67(12):5628-34. PubMed ID: 17575128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by Cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma.
    Handra-Luca A; Hernandez J; Mountzios G; Taranchon E; Lacau-St-Guily J; Soria JC; Fouret P
    Clin Cancer Res; 2007 Jul; 13(13):3855-9. PubMed ID: 17606717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck.
    Wang LE; Sturgis EM; Eicher SA; Spitz MR; Hong WK; Wei Q
    Clin Cancer Res; 1998 Jul; 4(7):1773-8. PubMed ID: 9676854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing ERCC1 protein expression, mRNA levels, and genotype in squamous cell carcinomas of the head and neck treated with concurrent chemoradiation stratified by HPV status.
    Hao D; Lau HY; Eliasziw M; Box A; Diaz R; Klimowicz AC; Shin B; Lees-Miller SP; Magliocco AM
    Head Neck; 2012 Jun; 34(6):785-91. PubMed ID: 22127805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERCC1, XPD and RAI mRNA levels in lymphocytes are not associated with lung cancer risk in a prospective study of Danes.
    Vogel U; Nexø BA; Tjønneland A; Wallin H; Hertel O; Raaschou-Nielsen O
    Mutat Res; 2006 Jan; 593(1-2):88-96. PubMed ID: 16054657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of genetic susceptibility for development of squamous epithelial carcinomas of the had and neck with bleomycin-induced chromosome instability].
    Cloos J; Snow GB; Braakhuis BJ
    Laryngorhinootologie; 1995 Dec; 74(12):742-7. PubMed ID: 8579674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysis.
    Li Y; Gu S; Wu Q; Li Y; Fu X; Mao Y; Huang Y; Xie Y
    Eur J Hum Genet; 2007 Sep; 15(9):967-73. PubMed ID: 17522621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
    Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
    J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.